These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

175 related items for PubMed ID: 1281377

  • 1. Renal hyperfiltration states: relationship to kallikrein and kinins.
    Mayfield RK, Jaffa AA, Edmundson AW, Harvey JN.
    Agents Actions Suppl; 1992; 38 ( Pt 3)():142-8. PubMed ID: 1281377
    [Abstract] [Full Text] [Related]

  • 2. Evidence for renal kinins as mediators of amino acid-induced hyperperfusion and hyperfiltration in the rat.
    Jaffa AA, Vio CP, Silva RH, Vavrek RJ, Stewart JM, Rust PF, Mayfield RK.
    J Clin Invest; 1992 May; 89(5):1460-8. PubMed ID: 1373739
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Kinin, a mediator of diabetes-induced glomerular hyperfiltration.
    Jaffa AA, Rust PF, Mayfield RK.
    Diabetes; 1995 Feb; 44(2):156-60. PubMed ID: 7859934
    [Abstract] [Full Text] [Related]

  • 6. Modulation of renal kallikrein production by dietary protein in streptozotocin-induced diabetic rats.
    Jaffa AA, Silva RH, Kim B, Mayfield RK.
    J Am Soc Nephrol; 1996 May; 7(5):721-7. PubMed ID: 8738807
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Functional, biochemical, and molecular investigations of renal kallikrein-kinin system in diabetic rats.
    Tschöpe C, Reinecke A, Seidl U, Yu M, Gavriluk V, Riester U, Gohlke P, Graf K, Bader M, Hilgenfeldt U, Pesquero JB, Ritz E, Unger T.
    Am J Physiol; 1999 Dec; 277(6):H2333-40. PubMed ID: 10600853
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. The kallikrein-kinin system in pregnancy and parturition in the rat: use of the kallikrein inhibitor aprotinin to prolong parturition [proceedings].
    Whalley ET, Riley AJ.
    J Endocrinol; 1978 May; 77(2):20P-21P. PubMed ID: 307044
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Effect of KATP channel blocker U37883A on renal function in experimental diabetes mellitus in rats.
    Vallon V, Albinus M, Blach D.
    J Pharmacol Exp Ther; 1998 Sep; 286(3):1215-21. PubMed ID: 9732381
    [Abstract] [Full Text] [Related]

  • 17. The effect of aprotinin (a serine protease inhibitor) on renal function and renin release.
    Seto S, Kher V, Scicli AG, Beierwaltes WH, Carretero OA.
    Hypertension; 1983 Sep; 5(6):893-9. PubMed ID: 6197374
    [Abstract] [Full Text] [Related]

  • 18. Kinins are involved in the antiproteinuric effect of angiotensin-converting enzyme inhibition in experimental diabetic nephropathy.
    Tschöpe C, Seidl U, Reinecke A, Riester U, Graf K, Schultheiss HP, Hilgenfeldt U, Unger T.
    Int Immunopharmacol; 2003 Mar; 3(3):335-44. PubMed ID: 12639811
    [Abstract] [Full Text] [Related]

  • 19. The effects of atrial natriuretic peptide and amiloride on renal haemodynamics and the renal kallikrein-kinin system.
    Seino M, Abe K, Nushiro N, Omata K, Yoshinaga K.
    J Hypertens; 1988 Apr; 6(4):321-7. PubMed ID: 2967862
    [Abstract] [Full Text] [Related]

  • 20. [The role of the kallikrein-kinin system in the pathogenesis of leptospirosis].
    Kecskés B.
    Orv Hetil; 1994 Aug 28; 135(35):1913-7. PubMed ID: 8072763
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.